Treatment

Dose Level 3 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer
This study looks at combining two drugs, Idetrexed and olaparib, to treat a type of ovarian cancer (high-grade serous) that hasn't responded to usual treatments. The goal is to see if this combination can target cancer cells more effectively.
For: High Grade Serous Ovarian Cancer
United Kingdom